Candriam S.C.A. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001537014

What is a 13F filing? Who files one and when · What 13F filings can't tell you

LargeTechnology TiltHigh Turnover how tags are computed

Q2 2024 · 653 positions · Total reported value $16.08B · Top-10 concentration 30.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 47.4% · 21 new · 252 cut · 51 exited

Active Share (vs S&P 500): 37.1% · vs QQQ: 52.6% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -0.6% · vs SPY -2.8% · Prev Value $22.00B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -1.7% · vs SPY -3.9% · Latest Value $22.25B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2024 13F filing, Candriam S.C.A. disclosed 653 equity positions with a combined reported value of $16.08B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 30.9% of reported value. HoldingsHub classifies the profile as Large / Technology Tilt / High Turnover.

The largest disclosed positions as of Q2 2024 were MSFT ($1.10B), NVDA ($848.60M), AAPL ($748.92M). By sector, the heaviest allocations are Technology 37.1%, Health Care 22.8%. Versus the prior quarter, allocation shifted toward Technology (+2.4pp), Financials (+1.2pp) and away from Other (-0.8pp), Industrials (-0.8pp).

Versus the prior quarter, Candriam S.C.A. opened 21 new positions, trimmed 252 and fully exited 51, a turnover rate of 47.4% of positions. The portfolio's overlap with the prior quarter was 86% of names.

The largest new positions opened in Q2 2024 were BMA ($43.24M), MIRM ($17.38M), AGIO ($13.92M).

Of the 51 positions fully exited versus the prior quarter, the largest were ALPN ($16.45M), BBIO ($11.75M), FOLD ($9.42M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2024)

  • BMA BANCO MACRO S A · $43.24M
  • MIRM MIRUM PHARMACEUTICALS INC · $17.38M
  • AGIO AGIOS PHARMACEUTICALS INC · $13.92M
  • ALLY ALLY FINL INC · $12.76M
  • ARQT ARCUTIS BIOTHERAPEUTICS INC · $12.16M
  • VRNA VERONA PHARMA ADR PLC ADR · $11.18M
  • RYTM RHYTHM PHARMACEUTICALS INC · $11.14M
  • ANNX ANNEXON INC · $10.06M

Fully Exited (vs previous quarter)

  • ALPN ALPINE IMMUNE SCIENCES INC · prev qtr: $16.45M
  • BBIO BRIDGEBIO PHARMA INC · prev qtr: $11.75M
  • FOLD AMICUS THERAPEUTICS INC · prev qtr: $9.42M
  • WYNN WYNN RESORTS LTD · prev qtr: $9.08M
  • FDMT 4D MOLECULAR THERAPEUTICS IN · prev qtr: $8.57M
  • EDU NEW ORIENTAL ED & TECHNOLOGY · prev qtr: $7.99M
  • ACAD ACADIA PHARMACEUTICALS INC · prev qtr: $7.50M
  • EVH EVOLENT HEALTH INC · prev qtr: $6.07M

Insider Transactions (Form 4)

Latest Candriam S.C.A. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Candriam S.C.A. is a Luxembourg-based asset management firm founded in 1989, now part of New York Life Investments, with headquarters in Strassen, Luxembourg. The firm employs a responsible investment approach integrating ESG factors across various asset classes.

Investment Approach

Responsible investment with ESG integration, combining quantitative and fundamental research, offering both active and passive investment strategies

Asset Classes

Equities, fixed income, alternatives, multi-asset solutions

Notable Facts

Part of New York Life Investments, strong focus on sustainable investing, acquired in 2018

AUM

$154.7B (SEC Form ADV regulatory figure)

Official disclosures available through SEC filings

Sector Allocation

Technology 37.1%
Health Care 22.8%
Financials 7.3%
Utilities 2.6%
Other 6.2%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 2.46M $1.10B 6.82%
6.82%
Hold
2 6.87M $848.60M 5.28%
5.28%
Add
3 3.56M $748.92M 4.66%
4.66%
Reduce
4 3.05M $556.33M 3.46%
3.46%
Hold
5 485.62K $439.65M 2.73%
2.73%
Add
6 2.38M $294.69M 1.83%
1.83%
Reduce
7 1.50M $290.07M 1.80%
1.80%
Add
8 431.66K $238.70M 1.49%
1.49%
Add
9 450.37K $229.34M 1.43%
1.43%
Add
10 831.37K $218.20M 1.36%
1.36%
Add
11 200.71K $210.94M 1.31%
1.31%
Reduce
12 610.17K $190.64M 1.19%
1.19%
Reduce
13 1.11M $183.69M 1.14%
1.14%
Add
14 413.19K $182.28M 1.13%
1.13%
Add
15 951.98K $174.60M 1.09%
1.09%
Hold
16 676.56K $159.65M 0.99%
0.99%
Add
17 328.27K $153.86M 0.96%
0.96%
Reduce
18 94.18K $151.20M 0.94%
0.94%
Add
19 803.10K $139.58M 0.87%
0.87%
Add
20 2.02M $138.58M 0.86%
0.86%
Reduce
21 634.19K $135.29M 0.84%
0.84%
Reduce
22 170.16K $133.85M 0.83%
0.83%
Reduce
23 512.33K $131.71M 0.82%
0.82%
Reduce
24 381.54K $131.34M 0.82%
0.82%
Add
25 962.68K $126.62M 0.79%
0.79%
Reduce
26 114.52K $121.94M 0.76%
0.76%
Reduce
27 609.64K $121.42M 0.76%
0.76%
Add
28 372.43K $114.61M 0.71%
0.71%
Add
29 246.87K $109.81M 0.68%
0.68%
Reduce
30 655.36K $106.30M 0.66%
0.66%
Reduce
31 309.93K $105.06M 0.65%
0.65%
Add
32 953.71K $105.06M 0.65%
0.65%
Reduce
33 409.47K $102.30M 0.64%
0.64%
Reduce
34 496.82K $100.48M 0.62%
0.62%
Add
35 1.34M $99.76M 0.62%
0.62%
Reduce
36 365.85K $87.07M 0.54%
0.54%
Add
37 6.67M $85.96M 0.54%
0.54%
Add
38 1.80M $85.72M 0.53%
0.53%
Add
39 169.06K $85.24M 0.53%
0.53%
Add
40 358.91K $83.10M 0.52%
0.52%
Add
41 50.53K $83.04M 0.52%
0.52%
Reduce
42 389.15K $82.28M 0.51%
0.51%
Add
43 415.08K $82.13M 0.51%
0.51%
Reduce
44 212.88K $81.57M 0.51%
0.51%
Reduce
45 20.37K $80.68M 0.50%
0.50%
Add
46 1.32M $80.00M 0.50%
0.50%
Reduce
47 438.63K $79.68M 0.50%
0.50%
Add
48 130.50K $77.04M 0.48%
0.48%
Add
49 343.50K $71.34M 0.44%
0.44%
Add
50 403.51K $70.76M 0.44%
0.44%
Reduce

FAQ

What did Candriam S.C.A. buy in 2024-Q2?

In its 2024-Q2 13F filing, Candriam S.C.A. reported 653 equity positions worth $16.08B in aggregate; its largest disclosed positions were MSFT ($1.10B), NVDA ($848.60M), AAPL ($748.92M).

How large is Candriam S.C.A.'s portfolio?

Candriam S.C.A. reported $16.08B of long equity holdings across 653 positions as of 2024-Q2. Top-10 holdings account for 30.9% of reported value.

What is Candriam S.C.A.'s investment style?

HoldingsHub classifies the portfolio as Large / Technology Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/candriam-s-c-a/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →